Study of MLN2480 in Participants With Relapsed or Refractory Solid Tumors Followed by a Dose Expansion in Participants With Metastatic Melanoma
Clinical trial NCT01425008 · COMPLETED
Trial details
- NCT number
- NCT01425008
- Sponsor
- Millennium Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-09-15
- Primary completion
- 2017-04-11
- Enrollment
- 149
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.